Recruiting
Phase 1

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Sponsor:

Retina Research Foundation

Code:

NCT00695682

Conditions

Diabetic Retinopathy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

intravitreal injection of infliximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information